These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 30604156)

  • 1. Clinical target sequencing for precision medicine of breast cancer.
    Tsuchida J; Rothman J; McDonald KA; Nagahashi M; Takabe K; Wakai T
    Int J Clin Oncol; 2019 Feb; 24(2):131-140. PubMed ID: 30604156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.
    Wakai T; Prasoon P; Hirose Y; Shimada Y; Ichikawa H; Nagahashi M
    Int J Clin Oncol; 2019 Feb; 24(2):115-122. PubMed ID: 30515675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
    Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
    Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.
    Stover DG; Wagle N
    Curr Oncol Rep; 2015 Apr; 17(4):15. PubMed ID: 25708799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The possibility of clinical sequencing in the management of cancer.
    Kou T; Kanai M; Matsumoto S; Okuno Y; Muto M
    Jpn J Clin Oncol; 2016 May; 46(5):399-406. PubMed ID: 26917600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-Generation Sequencing-Based Biomarkers in Breast Cancer.
    Han W; Lim W
    Adv Exp Med Biol; 2021; 1187():323-335. PubMed ID: 33983586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection.
    Kou T; Kanai M; Kamada M; Nakatsui M; Matsumoto S; Okuno Y; Muto M
    Methods Mol Biol; 2018; 1825():413-424. PubMed ID: 30334215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
    Rozenblum AB; Ilouze M; Dudnik E; Dvir A; Soussan-Gutman L; Geva S; Peled N
    J Thorac Oncol; 2017 Feb; 12(2):258-268. PubMed ID: 27865871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.
    Lang GT; Jiang YZ; Shi JX; Yang F; Li XG; Pei YC; Zhang CH; Ma D; Xiao Y; Hu PC; Wang H; Yang YS; Guo LW; Lu XX; Xue MZ; Wang P; Cao AY; Ling H; Wang ZH; Yu KD; Di GH; Li DQ; Wang YJ; Yu Y; Shi LM; Hu X; Huang W; Shao ZM
    Nat Commun; 2020 Nov; 11(1):5679. PubMed ID: 33173047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Top advances of the year: Precision oncology.
    Desai A; Reddy NK; Subbiah V
    Cancer; 2023 Jun; 129(11):1634-1642. PubMed ID: 36946766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.
    De Luca F; Rotunno G; Salvianti F; Galardi F; Pestrin M; Gabellini S; Simi L; Mancini I; Vannucchi AM; Pazzagli M; Di Leo A; Pinzani P
    Oncotarget; 2016 May; 7(18):26107-19. PubMed ID: 27034166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of HER2 mutations in refractory metastatic breast cancers: targeted sequencing results in patients with refractory breast cancer.
    Park YH; Shin HT; Jung HH; Choi YL; Ahn T; Park K; Lee A; Do IG; Kim JY; Ahn JS; Park WY; Im YH
    Oncotarget; 2015 Oct; 6(31):32027-38. PubMed ID: 26397225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    PĂ©cuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing.
    Liu S; Wang H; Zhang L; Tang C; Jones L; Ye H; Ban L; Wang A; Liu Z; Lou F; Zhang D; Sun H; Dong H; Zhang G; Dong Z; Guo B; Yan H; Yan C; Wang L; Su Z; Li Y; Huang XF; Chen SY; Zhou T
    Hum Genomics; 2015 Feb; 9(1):2. PubMed ID: 25757876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic diagnosis of breast cancer patients: evolution of the traditional clinical-pathologic paradigm toward "precision" cancer therapy.
    Turner BM; Hicks DG
    Biotech Histochem; 2017; 92(3):175-200. PubMed ID: 28318327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Evolution as the New Frontier of Precision Medicine.
    Curigliano G
    Handb Exp Pharmacol; 2018; 249():289-297. PubMed ID: 30406442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An institutional review of genomic sequencing in pediatric solid tumors.
    Turco GM; Gupta A; Monteleone P; Kelly KM; Klein RD; Wiltsie L; Barth M
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30324. PubMed ID: 37017066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.
    Gonçalves A; Bertucci F; Guille A; Garnier S; Adelaide J; Carbuccia N; Cabaud O; Finetti P; Brunelle S; Piana G; Tomassin-Piana J; Paciencia M; Lambaudie E; Popovici C; Sabatier R; Tarpin C; Provansal M; Extra JM; Eisinger F; Sobol H; Viens P; Lopez M; Ginestier C; Charafe-Jauffret E; Chaffanet M; Birnbaum D
    Oncotarget; 2016 Nov; 7(48):79428-79441. PubMed ID: 27765906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.